Sep 8, 2026, 8:09 PM1 views

Sun Pharma gets ratings boost from Moody's, S&P over $11.75-bn Organon bid

Rating agencies Moody's and S P assigned investment-grade ratings to Sun Pharmaceutical Industries -- India's largest pharmaceutical company -- over the proposed USD 11.75-billion acquisition of US-based Organon Co. S…

Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries -- India's largest pharmaceutical company -- over the proposed USD 11.75-billion acquisition of US-based Organon & Co. S&P Global Ratings assigned a preliminary 'BBB+' long-term issuer credit rating, while Moody's Ratings assigned a 'Baa1' long-term issuer rating to the Indian pharmaceutical major. Both agencies have maintained a 'stable' outlook for the company. Baa1 and BBB+ are investment-grade credit ratings that indicate adequate payment capacity with moderate credit risk. The rating actions follow Sun Pharma's binding bid in April 2026 to acquire a 100 per cent stake in Organon for an enterprise value of USD 11.75 billion. The transaction is expected to close by March 2027, subject to regulatory approvals. According to S&P, the acquisition will bolster Sun Pharma's business position, almost doubling its revenue base to about Rs 1.3 trillion (around USD 14 billion) ..

Business-standard Verified Source

Syndicated via official news feed

Read Full Story on Business-standard

Explore all Business stories

Syndicated feed content with full publisher credit.

Business Desk

More in Business

Continue reading verified coverage and related developments on this desk.

View All

BUSINESS14M AGO

NASCAR Is Targeting the Young Fans, CEO Says

Steve O'Donnell, NASCAR CEO, says the business has good momentum but he's still focused on attracting younger viewers and getting new fans to the track. He also talks about competition among the drivers and how that…

BUSINESS16M AGO

Millennium Nears $100 Billion as Giant Hedge Funds Enter New Era

Millennium Management's assets have hit $97 billion, more than double what the firm oversaw six years ago, and is speeding toward $100 billion. Hema Parmar reports on Bloomberg Open Interest. (Source: Bloomberg)

BUSINESS20M AGO

Firms Seek to Lower Borrowing Costs in Flurry of US Repricings

Companies are flocking to the US leveraged loan market with offerings to reprice large chunks of existing debt, tapping strong investor demand to reduce borrowing costs.

BUSINESS23M AGO

Luxury Whiskey Bets on Ready-Made Cocktails

Julie Macklowe, the Founder of the luxury whiskey brand Macklowe, joined Bloomberg Open Interest to talk about how tariffs on liquor ultimately punish American consumers through higher prices, and may even be…

BUSINESS27M AGO

Saudi Arabia Halts Energy Sites as Houthis Claim New Attacks

Saudi Arabia halted several energy facilities in the south, as the Iran-backed Houthi militants claimed fresh strikes on the kingdom. The Yemen-based Houthis said they targeted Saudi Aramco’s facilities in Abha, Najran…

BUSINESS35M AGO

Carney Says Tariffs on US Goods Meant to Protect Canada, Not Escalate Conflict

Prime Minister Mark Carney said he doesn’t believe in escalating the trade war with the US, but he argued counter-tariffs are necessary to cushion the blow for Canadian businesses and workers.